'Cure All Diseases in 5 Years' Pushed Back: Bottleneck Is Clinical Funding, Not Targets
shae_mcl · x · 2026-08-18
Pushing back on the claim that AI will cure all diseases within 5 years, biotech investor Ryan Bethencourt argues the bottleneck isn't finding targets — university IP offices are full of patents collecting dust. The real problem is funding pre-clinical and clinical research: everyone wants cures, but no one wants to wait a decade and pay over $1B for them. That, not more (admittedly great) targets or molecules, is the challenge. shaemcl adds that we don't even have suitable targets for all diseases sitting on shelves.
More from AGI Musings
- Vinod Khosla: Humans degrade the performance of good AI — Scobleizer · 2026-08-18
- Neolab Onboarding: OpenAI and Anthropic Both Racing to the Bottom on Safety — nabla_theta · 2026-08-18
- Gordian Founder: Verifiability Means AI Cracks Cancer Before Alzheimer's — MaxUnfried · 2026-08-18
- Regulate unlawful conduct, not the AI tool itself, argues legal commentator — TinfoilTricorn · 2026-08-18
- Lawyers' AI-Assisted Filings Face Court Rules Raising First Amendment Concerns — TinfoilTricorn · 2026-08-18
- Expensive cognitive labor has bigger incentive to automate — VraserX · 2026-08-18